We greatly appreciate the generous foundations, organizations, individuals and collaborative ventures which enable us to do our research. We cannot thank these people enough. 

NF Research Initiative (NFRI)

The mission of the NF1 Research Initiative (NFRI) is to advance pre-clinical research towards effective treatment of neurofibromatosis-related tumors. The initial focus of the NFRI will be on malignant peripheral nerve sheath tumors (MPNSTs), for which there is currently no effective medical treatment. The NFRI will accomplish this mission through two primary objectives: (1) Collaboration with international experts to collect MPNSTs and define their genomic architecture, combine genomic data with relevant clinical information, and make the data available as an open resource to identify drivers of tumor progression. This effort will take the form of a “Genomics of MPNST” (GeM) Consortium. (2) Directing an international open grant program to fund pre-clinical research proposals taking novel approaches aimed at advancing effective medical treatment(s) for MPNSTs.

Sarcoma Alliance for Research through Collaboration (SARC)

SARC (Sarcoma Alliance for Research through Collaboration) is a non-profit organization dedicated to the development and support of research for the prevention, treatment, and cure of sarcomas  –  a cancer of the bone and connective tissue of the body. SARC was founded by a small group of physicians specializing in sarcoma. Recognizing the value of pooling their intellectual and patient resources, a core group of medical and pediatric sarcoma experts at five major medical facilities formed SARC in 2003 to conduct innovative and rigorous sarcoma research to advance the care of their patients. Today, the leadership of SARC consists of respected sarcoma physicians across the country, working together to develop new strategies to improve the outcomes for sarcoma patients.

Doris Duke Foundation

In her will, Doris Duke left her fortune, her properties and her extensive collections of art to a foundation to be created in her name: the Doris Duke Charitable Foundation. The foundation has developed its activities based on her written guidance as well as the personal passions that she pursued throughout her life. With this approach, the mission of the Doris Duke Charitable Foundation is to improve the quality of people’s lives through grants. Doris Duke was a significant supporter of medical research, making contributions to hospitals and research centers throughout her life. In her will, she expressed her interest in supporting “medical research designed to effectuate cures of major diseases.”

Neurofibromatosis Therapy Acceleration Program (NTAP)

The Neurofibromatosis Therapeutic Acceleration Program (NTAP) is focused exclusively on improving treatment options for people living with Neurofibromatosis type 1-related plexiform neurofibromas. With the goal of therapeutics always in mind, initiatives span research that probes the basic aspects of tumorgenesis through clinical investigations of drugs that have the highest likelihood of having a positive impact for patients. NTAP’s approach is defined by (1) intense collaboration both within and outside of the neurofibromatosis research community and (2) ongoing critical assessment of the existing needs and opportunities for developing effective plexiform neurofibroma therapeutics.

American Cancer Society

At the American Cancer Society, we’re on a mission to free the world from cancer. Until we do, we’ll be funding and conducting research, sharing expert information, supporting patients, and spreading the word about prevention. All so you can live longer — and better. What does it take to outsmart cancer? Research. We’ve invested more than $4.8 billion in cancer research since 1946, all to find more – and better – treatments, uncover factors that may cause cancer, and improve cancer patients’ quality of life.

St. Louis Mens Group Against Cancer

St. Louis Men’s Group Against Cancer is a charitable organization whose purposes include raising funds that are directed to specific cancer-related organizations that focus on research, prevention, and care activities in the St. Louis community. Past recipient funds are channeled through various organizations and earmarked for specific programs in the thirty plus charities that benefit the St Louis cancer community. Since 1969, this independent organization has raised more than $4 million to direct funds not just to specific institutions, but to specific projects within those institutions.

Congressionally Directed Medical Research Programs (CDMRP)

The CDMRP fills research gaps by funding high impact, high risk and high gain projects that other agencies may not venture to fund. While individual programs are unique in their focus, all of the programs managed by the CDMRP share the common goal of advancing paradigm shifting research, solutions that will lead to cures or improvements in patient care, or breakthrough technologies and resources for clinical benefit. The CDMRP strives to transform healthcare for Service Members and the American public through innovative and impactful research.

Individual Donors

A special thank you to the individual families that provide support to our research.

  • The Brown Family
  • The Wascher Family
  • Kayla Brown and the Langham Family
  • Grace Kim and Family
  • The Roberts Family
  • Sarah Kim